MindMed to Participate in H.C. Wainwright Global Investment Conference

Rhea-AI Summary

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) announced its participation in the H.C. Wainwright 24th Annual Global Investment Conference, with its presentation accessible from 7:00 a.m. ET on September 12, 2022. As a clinical stage biopharmaceutical company, MindMed focuses on developing innovative treatments for brain health disorders. The company aims to enhance patient outcomes through its drug candidates targeting serotonin, dopamine, and acetylcholine systems. A replay of the presentation will be available in the 'News & Media' section of MindMed's website.

NEW YORK, Sept. 7, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that it will participate virtually at the H.C. Wainwright 24th Annual Global Investment Conference, and its presentation will be available beginning at 7:00 a.m. ET on September 12, 2022.

For details or to register to attend please visit https://hcwevents.com/annualconference/. A replay of the webcast will be available in the "News & Media" section of MindMed's website.

About MindMed

MindMed is a clinical stage biopharmaceutical company developing novel products to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems.

MindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.

For Media: media@mindmed.co

For Investors: ir@mindmed.co

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/mindmed-to-participate-in-hc-wainwright-global-investment-conference-301619002.html

SOURCE Mind Medicine (MindMed) Inc.

FAQ

What is the date and time of MindMed's presentation at the H.C. Wainwright conference?

MindMed's presentation will be available starting at 7:00 a.m. ET on September 12, 2022.

Where can I watch the replay of MindMed's conference presentation?

The replay will be available in the 'News & Media' section of MindMed's website.

What is the ticker symbol for Mind Medicine?

Mind Medicine trades on NASDAQ under the symbol MNMD.

What type of company is Mind Medicine?

Mind Medicine is a clinical stage biopharmaceutical company developing treatments for brain health disorders.

What is the focus of MindMed's drug development?

MindMed focuses on innovative drug candidates targeting the serotonin, dopamine, and acetylcholine systems.